West Chester, PA – December 14, 2022 /OrthoSpineNews/ – Altus Spine, a leader in the development and innovation of medical devices used in spinal correction surgery, hosted a successful interactive Open and MIS Lumbar Fusion Bioskills Lab at the 2022 Spine IEP Fellows and Young Surgeons Course in Austin, TX.
This course, developed specifically for Spine and Neuro Fellows and Young Surgeons on current topics on the practice of spine/neurosurgery, is geared to assist with the transition from Fellow to practicing surgeon.
The Altus Team had the opportunity to meet with many fellows and surgeon attendees, and cover the latest advances and innovative products in their dynamic portfolio. To further the attendees’ experience at the course, Altus Spine also hosted a hands-on bioskills lab. Led by Altus Spine’s surgeon faculty members, Bradley Moatz, M.D. and Danny Liang, M.D., the Fundamentals of Open and MIS Lumbar Fusion Bioskills Lab took the attendees through both an Open and an MIS Lumbar Fusion using Altus solutions. From approach, targeting & imaging, decompression, and instrumentation, the attendees had the opportunity to experience both options for this procedure. 
The lab attendees had the opportunity to experience an array of Altus Spine’s innovative products including: Valencia MIS Pedicle Screw System, Interlagos Retractor System, Silverstone Titanium IBF System, Posterior Disc Prep Systems and their Monaco Pedicle Screw System.
“Our team was very pleased to have been able to provide sponsorship for a meeting that is so important for our fellows and young surgeons,” said Michael Fitzgerald, President and CEO, “The meeting, along with our Bioskills Lab, was a huge success and we look forward to supporting similar meetings that provide such great training and educational opportunities for our surgeons.”
Altus Spine
Based in West Chester, PA, Altus Spine is dedicated to creating the next generation of medical devices. Altus strives to improve patient care by designing and manufacturing products to meet the highest standards in an ever changing and evolving field. Implemented and used by over 100 hospitals across the United States, Altus is among the fastest growing spinal implant companies in the world. For additional information, or to inquire about distribution opportunities, please contact us at info@altus-spine.com.
Forward Looking Statements
All statements made in the above press release, with the exception of historical fact, may be forward-looking statements that include risk, uncertainty, and assumptions. These factors could cause Altus Spine’s results to differ from those predicted if they do not occur as expected. These uncertain factors include, but are not limited to: acceptance and clearance of the company’s surgical products and procedures, development of new products and procedures, innovations and alterations to existing products and procedures, clinical and statistical verification of the success using Altus Spine’s products, company’s ability to maintain and monitor inventory as it releases new products, its ability to hire and retain personnel, and any other risks stated in prior or subsequent news releases. All risks and potential complications can be found in our most recent 510(k) report from the Food and Drug Administration (FDA). Given the constantly changing market, readers are encouraged to not place undue reliance on forward-looking statements. Altus Spine assumes no obligation to update forward-looking statements as these changes occur, or as events and circumstances are altered, after the date they are posted.
For more information, contact us at info@altus-spine.com
